中文产业新闻精选评分71Chinese source
药捷安康FGFR抑制剂替恩戈替尼片获NMPA批准上市
时隔两月，全市第二个1类新药！
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
时隔两月，全市第二个1类新药！
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.